ZDHHC9 and adenocarcinoma: Furthermore, through a comprehensive small‐molecule virtual screening approach, we identified two potent DHHC9 inhibitors, Treprostinil and 10‐HCPT, which effectively suppress DHHC9 activity and inhibit adenocarcinoma cell migration (Figure S6).